David E. Gerber
Parkland Health & Hospital System(US)Southwestern Medical Center(US)Southwestern Medical CenterThe University of Texas Southwestern Medical Center(US)The University of Texas Southwestern Medical Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer(2015)9,390 cited
- → Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer(2017)1,010 cited
- → Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study(2016)952 cited
- → Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events(2021)772 cited
- → Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment(2010)761 cited
- → Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer(2021)624 cited